- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Indegene Launches Metaverse Capabilities
Indegene, a digital-first, life sciences commercialization company will provide life sciences organizations a foundation for navigating the complexity of this emerging technology and the flexibility to create tailored virtual worlds. Using these, life sciences organizations can foster immersive healthcare experiences, like interactions with HCPs in a virtual medical congress, meeting for a virtual educational lecture, or facilitating interactions in a virtual patient hub.
“Life sciences organizations are looking to reimagine healthcare interactions and be ahead of the curve. Providing new ways to connect, educate, and lead transformation using virtual and augmented reality can help solve some of their key business challenges,” said Gaurav Kapoor, Executive Vice President, Indegene, Inc.
“We are excited to bring to our clients the ability to create immersive experiences to aid seamless and richer engagements with HCPs and patients. Indegene’s metaverse capabilities to design highly personalized virtual worlds, coupled with our experience and deep domain expertise, enables life sciences companies to be future ready.”
Beyond the Scrubs: Understanding Healthcare Providers as People for Increased Engagement
March 28th 2024The benefits of adopting a humanized approach to healthcare provider marketing extend across the healthcare spectrum, enhancing engagement rates, brand loyalty, and marketing ROI, while also driving better outcomes for patients.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
